Your session is about to expire
← Back to Search
Smart Watch for Atrial Fibrillation
N/A
Waitlist Available
Led By Dhanunjaya Lakkireddy
Research Sponsored by Kansas City Heart Rhythm Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights
Study Summary
This trial is testing how well a wearable smart watch can detect atrial fibrillation and other arrhythmias compared to data from implantable loop recorders.
Eligible Conditions
- Atrial Fibrillation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
AFib detection with heart rate data measured by Smart Watch
Trial Design
1Treatment groups
Experimental Treatment
Group I: Smart WatchExperimental Treatment1 Intervention
The patients will wear the Smart Watch to generate data to assess their rhythm as confirmed by the ILR done during the same time.
Find a Location
Who is running the clinical trial?
Kansas City Heart Rhythm Research FoundationLead Sponsor
26 Previous Clinical Trials
11,956 Total Patients Enrolled
13 Trials studying Atrial Fibrillation
4,292 Patients Enrolled for Atrial Fibrillation
Dhanunjaya LakkireddyPrincipal InvestigatorKansas City Heart Rhythm Institute
11 Previous Clinical Trials
9,070 Total Patients Enrolled
6 Trials studying Atrial Fibrillation
3,210 Patients Enrolled for Atrial Fibrillation
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger